Modulation of 5-fluorouracil by interferon: a review of potential cellular targets

Robert Horowitz, Edward L. Schwartz, Scott Wadler

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalMedical Oncology
Volume12
Issue number1
DOIs
StatePublished - Mar 1995

Fingerprint

Pathologic Neovascularization
Thymidine Phosphorylase
Cultured Tumor Cells
Thymidylate Synthase
Combined Modality Therapy
Fluorouracil
Antineoplastic Agents
Thymidine
Interferons
Cell Cycle
Neoplasms

Keywords

  • 5-fluorouracil
  • interferon

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Modulation of 5-fluorouracil by interferon : a review of potential cellular targets. / Horowitz, Robert; Schwartz, Edward L.; Wadler, Scott.

In: Medical Oncology, Vol. 12, No. 1, 03.1995, p. 3-8.

Research output: Contribution to journalArticle

@article{2a2a678fe73b44c09fb2ca30bd8035c3,
title = "Modulation of 5-fluorouracil by interferon: a review of potential cellular targets",
keywords = "5-fluorouracil, interferon",
author = "Robert Horowitz and Schwartz, {Edward L.} and Scott Wadler",
year = "1995",
month = "3",
doi = "10.1007/BF01571402",
language = "English (US)",
volume = "12",
pages = "3--8",
journal = "Medical Oncology and Tumor Pharmacotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Modulation of 5-fluorouracil by interferon

T2 - a review of potential cellular targets

AU - Horowitz, Robert

AU - Schwartz, Edward L.

AU - Wadler, Scott

PY - 1995/3

Y1 - 1995/3

KW - 5-fluorouracil

KW - interferon

UR - http://www.scopus.com/inward/record.url?scp=0028844362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028844362&partnerID=8YFLogxK

U2 - 10.1007/BF01571402

DO - 10.1007/BF01571402

M3 - Article

C2 - 8542244

AN - SCOPUS:0028844362

VL - 12

SP - 3

EP - 8

JO - Medical Oncology and Tumor Pharmacotherapy

JF - Medical Oncology and Tumor Pharmacotherapy

SN - 0340-7004

IS - 1

ER -